Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-26 @ 12:43 AM
NCT ID:
NCT03941860
Group ID:
EG001
Title:
Arm B (Lenalidomide, Placebo)
Description:
Patients receive lenalidomide PO QD on days 1-28 and a placebo PO on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo bone marrow aspirate and/or biopsy and PET and CT scan at screening and on study as well as undergo collection of blood samples throughout the trial.
Biospecimen Collection: Undergo collection of blood samples
Bone Marrow Aspirate: Undergo bone marrow aspirate
Bone Marrow Biopsy: Undergo bone marrow biopsy
Computed Tomography: Undergo CT scan
Lenalidomide: Given PO
Placebo Administration: Given PO
Positron Emission Tomography: Undergo PET scan
Quality-of-Life Assessment: Ancillary studies
Questionnaire Administration: Ancillary studies
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
0
Other Number Affected:
0
Other Number At Risk:
0
Study:
NCT03941860
Results Section:
NCT03941860
Adverse Events Module:
NCT03941860